Montelukast dicarboxylic acid

CAS : 213380-27-9

Ref. 3D-NIA38027

Informations sur le produit

• Nom: Montelukast dicarboxylic acid

Description

Montelukast is a drug product that belongs to the class of drugs called leukotriene receptor antagonists. Montelukast binds to cysteinyl leukotrienes (LTC4, LTD4, LTE4) and prevents their interaction with receptors on the cell surface. It can be used for the treatment of asthma, chronic obstructive pulmonary disease, and other allergic conditions. Montelukast is available in tablet form and is taken orally. Montelukast is not expected to be toxic because it has been shown to have a low incidence of side effects in clinical trials.

Montelukast dicarboxylic acid (CAS No. 213380-27-9) is an impurity standard for HPLC analysis of montelukast products. It is a synthetic compound that has been custom synthesized for use as an impurity standard in order to meet the pharmacopoeia's requirements for purity and stability in pharmaceuticals

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 616.20 g/mol
• Formule: C₃₅H₃₄ClNO₅S
• Degré de pureté: Min. 95%